<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210427051104N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-06-26</date_registration>
      <primary_sponsor>Alborz University of Medical Sciences</primary_sponsor>
      <public_title>Evaluation of the effectiveness of low protein and low phenylalanine products (Zarmacaron) in the diet of people with phenylketonuria</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of low protein pasta with regular pasta on blood phenylalanine levels in children with phenylketonuria</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-07-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/56487</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Crossover, Purpose: Supportive, Randomization description: Individuals are divided into two groups by the randomized block method. The blocks will be selected in six and random numbers will be generated by Excel software to select the blocks.</study_design>
      <phase>N/A</phase>
      <hc_freetext>phenylketonuria.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: first receives the standard diet with low phenylalanine pasta and then the standard diet without diet products ---The first group uses the standard phenylketonuria diet with low phenylalanine pasta for one week. Then for a week all patients will be free to choose daily food (rest period similar to normal pre-study diet). Next, participants use a standard diet without diet cereal products for a week. It should be noted that all diets are designed equally in terms of the amount of phenylalanine. Therefore, the duration of the intervention will be 3 weeks. All patients are evaluated for food intake and blood phenylalanine levels at the beginning of the study, at the end of the first week, at the end of the second week, at the end of the study. Tests for patients include: evaluation of body composition using body analyzer, evaluation of food intake using a food record questionnaire, and blood tests, including serum phenylalanine level, which is performed 4 times per patient. Other biochemical indicators that are tested only at the beginning of the study to assess the nutritional status of patients includes: Tyr amino acid, CBC, FPG, Uric acid, Creatinine, Cholesterol, LDL, HDL, Triglyceride, Ferritin, B12, Folic acid, Homocysteine, 25-OH-VitaminD, Zinc, Prealbumin. Also, the level of satisfaction and adherence of the people to the diet in different phases is measured and scored. Intervention 2: Control group: first receives the standard diet without diet products and then the standard diet with low phenylalanine pasta--- Control group: first receives the standard diet without diet products and then the standard diet with low phenylalanine pasta---The first group uses the standard phenylketonuria diet without diet cereal products for one week. Then for a week all patients will be free to choose daily food (rest period similar to normal pre-study diet). Next, participants use a standard diet with low phenylalanine pasta for a week. It should be noted that all diets are designed equally in terms of the amount of phenylalanine. Therefore, the duration of the intervention will be 3 weeks. All patients are evaluated for food intake and blood phenylalanine levels at the beginning of the study, at the end of the first week, at the end of the second week, at the end of the study. Tests for patients include: evaluation of body composition using body analyzer, evaluation of food intake using a food record questionnaire, and blood tests, including serum phenylalanine level, which is performed 4 times per patient. Other biochemical indicators that are tested only at the beginning of the study to assess the nutritional status of patients includes: Tyr amino acid, CBC, FPG, Uric acid, Creatinine, Cholesterol, LDL, HDL, Triglyceride, Ferritin, B12, Folic acid, Homocysteine, 25-OH-VitaminD, Zinc, Prealbumin. Also, the level of satisfaction and adherence of the people to the diet in different phases is measured and scored.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can be shared.

When:
Access period starts 6 months after the results are published

To whom:
Researchers working in academic and scientific institutions

Conditions:
Decide on a case by case basis

Where to obtain:
Principal Investigator
Dr. Hoda Derakhshanian
h.derakhshanian@gmail.com

How to obtain:
After coordination with the principal investigator, the information will be available within one month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hoda Derakhshanian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nilufar Bldg., 1st Farhang Ave., Farhangestan Ave., West Hakim highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1486757628</zip>
        <telephone>+98 21 4609 6094</telephone>
        <email>h.derakhshanian@abzums.ac.ir</email>
        <affiliation>Alborz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hoda Derakhshanian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nilufar Bldg., 1st Farhang Ave., Farhangestan Ave., West Hakim highway</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1486757628</zip>
        <telephone>+98 21 4609 6094</telephone>
        <email>h.derakhshanian@abzums.ac.ir</email>
        <affiliation>Alborz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Children with phenylketonuria</inclusion_criteria>
      <agemin>1 year</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Reluctance to consume pasta
Suffering from other underlying diseases
Taking KUVAN drug
Parents' dissatisfaction with participation in the research project</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E70.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Classical phenylketonuria</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: first receives the standard diet with low phenylalanine pasta and then the standard diet without diet products ---The first group uses the standard phenylketonuria diet with low phenylalanine pasta for one week. Then for a week all patients will be free to choose daily food (rest period similar to normal pre-study diet). Next, participants use a standard diet without diet cereal products for a week. It should be noted that all diets are designed equally in terms of the amount of phenylalanine. Therefore, the duration of the intervention will be 3 weeks. All patients are evaluated for food intake and blood phenylalanine levels at the beginning of the study, at the end of the first week, at the end of the second week, at the end of the study. Tests for patients include: evaluation of body composition using body analyzer, evaluation of food intake using a food record questionnaire, and blood tests, including serum phenylalanine level, which is performed 4 times per patient. Other biochemical indicators that are tested only at the beginning of the study to assess the nutritional status of patients includes: Tyr amino acid, CBC, FPG, Uric acid, Creatinine, Cholesterol, LDL, HDL, Triglyceride, Ferritin, B12, Folic acid, Homocysteine, 25-OH-VitaminD, Zinc, Prealbumin. Also, the level of satisfaction and adherence of the people to the diet in different phases is measured and scored.</i_keyword>
      <i_keyword>Control group: first receives the standard diet without diet products and then the standard diet with low phenylalanine pasta--- Control group: first receives the standard diet without diet products and then the standard diet with low phenylalanine pasta---The first group uses the standard phenylketonuria diet without diet cereal products for one week. Then for a week all patients will be free to choose daily food (rest period similar to normal pre-study diet). Next, participants use a standard diet with low phenylalanine pasta for a week. It should be noted that all diets are designed equally in terms of the amount of phenylalanine. Therefore, the duration of the intervention will be 3 weeks. All patients are evaluated for food intake and blood phenylalanine levels at the beginning of the study, at the end of the first week, at the end of the second week, at the end of the study. Tests for patients include: evaluation of body composition using body analyzer, evaluation of food intake using a food record questionnaire, and blood tests, including serum phenylalanine level, which is performed 4 times per patient. Other biochemical indicators that are tested only at the beginning of the study to assess the nutritional status of patients includes: Tyr amino acid, CBC, FPG, Uric acid, Creatinine, Cholesterol, LDL, HDL, Triglyceride, Ferritin, B12, Folic acid, Homocysteine, 25-OH-VitaminD, Zinc, Prealbumin. Also, the level of satisfaction and adherence of the people to the diet in different phases is measured and scored</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Phenylalanine. Timepoint: Day 0, 7, 14 and 21 of intervention. Method of measurement: High Performance Liquid Chromatography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Diet compliance and satisfaction. Timepoint: Day 0, 7, 14 and 21 of intervention. Method of measurement: Questionnaire.</sec_outcome>
      <sec_outcome>Body composition. Timepoint: Day 0, 7, 14 and 21 of intervention. Method of measurement: Body analyzer - Inbody270.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Zarmacaron</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Alborz University of Medical Sciences</source_name>
      <source_name>Zarmacaron</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-03-06</approval_date>
        <contact_name>Ethics committee of Alborz University of Medical Sciences</contact_name>
        <contact_address>Vice chancellor for research and technology, Alborz University of medical Sciences, Saffarian St., Golshahr Ave., Karaj, Alborz Karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
